Icon
+91 94997 68112
Login Register

ELUCIREM - (1455.3MG/3ML, 3638.25MG/7.5ML, 4851MG/10ML, 7276.5MG/15ML, 14553MG/30ML, 24255MG/50ML, 48510MG/100ML)

GADOPICLENOL None
1455.3MG/3ML, 3638.25MG/7.5ML, 4851MG/10ML, 7276.5MG/15ML, 14553MG/30ML, 24255MG/50ML, 48510MG/100ML
Less Than $1000 mn
None None
None None
None None
ELUCIREM is a gadolinium-based contrast agent indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: • the central nervous system (brain, spine, and associated tissues), • the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).
Yes
ELUCIREM Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.